NOVATO, Calif., March 2, 2012 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (“Raptor” or the “Company”) (Nasdaq:RPTP) today announced that the Company has been upgraded to trade on the NASDAQ Global Market. Shares of Raptor’s common stock began trading on the NASDAQ Global Market on February 29, 2012 and will continue to be traded under the ticker RPTP.
